The inflammatory condition and thrombosis extend to varying degrees into the heart, gut, and kidneys [53], which means that SOCS expression must also be evaluated in different tissues from COVID‐19 patients to understand its impact on the regulation of the antiviral response. The gene discussed is CISH; the disease is COVID-19.